Jubilant Organosys

2005

Acquires Target Research Associates, Inc., renamed Clinsys Inc.; a US based Clinical Research Organisation (CRO)

Acquires Trinity Laboratories, Inc. and its wholly owned subsidiary, Trigen Laboratories, Inc., renamed Jubilant Pharmaceuticals, Inc., a generic pharmaceutical company in USA having a US FDA approved formulations manufacturing facility

Enters Clinsys Clinical Research Ltd. business by setting up wholly owned subsidiary Jubilant Clinsys Ltd.

2004

Sets up medicinal chemistry services business through wholly owned subsidiary Jubilant Chemsys Ltd.

Enters formulations and regulatory affairs businesses by acquiring Pharmaceuticals Services Incorporated, N.V. and PSI Supply N.V., the pharmaceutical companies in Europe.

2003

Sets up a new state-of-the-art Research & Development Centre in Noida, near New Delhi equipped with all latest scientific instruments.

2002

Acquires the Active Pharmaceutical Ingredients business

2001

New corporate identity: Jubilant Organosys Ltd. reflecting changed corporate and business profile

2000

Enters the Bio / chemo informatics arena by setting up Jubilant Biosys Ltd.

1998

Enters high value-added Pyridine derivates. Commissions Pyridine HBR and Cyano Pyridine plants.
Forms marketing subsidiary in the USA.
Acquires acetyl plant in western India.

1997

Commissions first Multi-purpose fine chemicals plant. Plant for food polymer commissioned.

1995

Gets ISO 9001 certification.

1990

Commissions Pyridine & Picoline plant.

1988

Launches its first branded product: Vamicol, an adhesive product.

1987

Introduces new products in Performance Chemicals segments: Poly vinyl acetate emulsion for paint, textile, paper & packaging and woodworking industry.

1985

Research & Development center gets recognition from Government of India.

1983

Commercial production of Vinyl Acetate Monomer (VAM).

1981

Initial Public Offering. Listing on leading stock exchanges of India.

1978

Incorporated as Vam Organic Chemicals Ltd.